Literature DB >> 9765433

A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system.

L Stitz1, K Nöske, O Planz, E Furrer, W I Lipkin, T Bilzer.   

Abstract

Borna disease virus (BDV) is a negative-strand RNA virus that infects the central nervous systems (CNS) of warm-blooded animals and causes disturbances of movement and behavior. The basis for neurotropism remains poorly understood; however, the observation that the distribution of infectious virus in immunocompetent rats is different from that in immunoincompetent rats indicates a role for the immune system in BDV tropism: whereas in immunocompetent rats virus is restricted to the central, peripheral, and autonomic nervous systems, immunoincompetent rats also have virus in nonneural tissues. In an effort to examine the influence of the humoral immune response on BDV pathogenesis, we examined the effects of passive immunization with neutralizing antiserum in immunoincompetent rats. Serum transfer into immunoincompetent rats did not prevent persistent CNS infection but did result in restriction of virus to neural tissues. These results indicate that neutralizing antibodies may play a role in preventing generalized infection with BDV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765433      PMCID: PMC110305     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].

Authors:  O Planz; P Seiler; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

2.  Virus-specific CD4+ T cells eliminate borna disease virus from the brain via induction of cytotoxic CD8+ T cells.

Authors:  K Nöske; T Bilzer; O Planz; L Stitz
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  The role of antibody concentration and avidity in antiviral protection.

Authors:  M F Bachmann; U Kalinke; A Althage; G Freer; C Burkhart; H Roost; M Aguet; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 4.  Immunopathogenesis of virus diseases affecting the central nervous system.

Authors:  T Bilzer; L Stitz
Journal:  Crit Rev Immunol       Date:  1996       Impact factor: 2.214

Review 5.  Immunopathogenesis of Borna disease.

Authors:  L Stitz; B Dietzschold; K M Carbone
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

6.  In vitro studies on Borna virus. I. The use of cell cultures for the demonstration, titration and production of Borna virus.

Authors:  K Danner; D Heubeck; A Mayr
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

7.  Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry.

Authors:  D Gonzalez-Dunia; B Cubitt; F A Grasser; J C de la Torre
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Biochemical and functional analysis of the Borna disease virus G protein.

Authors:  P A Schneider; C G Hatalski; A J Lewis; W I Lipkin
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 9.  Borna disease.

Authors:  C G Hatalski; A J Lewis; W I Lipkin
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

Review 10.  Borna disease virus and the brain.

Authors:  D Gonzalez-Dunia; C Sauder; J C de la Torre
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

View more
  24 in total

1.  Control of central nervous system viral persistence by neutralizing antibody.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Roscoe Atkinson; Stephen A Stohlman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.

Authors:  Madoka Sakai; Yoko Fujita; Ryo Komorizono; Takehiro Kanda; Yumiko Komatsu; Takeshi Noda; Keizo Tomonaga; Akiko Makino
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

3.  Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant.

Authors:  Marco Henkel; Oliver Planz; Timo Fischer; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology.

Authors:  E Furrer; T Bilzer; L Stitz; O Planz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Visualizing viral dissemination in the mouse nervous system, using a green fluorescent protein-expressing Borna disease virus vector.

Authors:  Andreas Ackermann; Timo Guelzow; Peter Staeheli; Urs Schneider; Bernd Heimrich
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Analysis of naturally occurring avian bornavirus infection and transmission during an outbreak of proventricular dilatation disease among captive psittacine birds.

Authors:  Amy L Kistler; Jeanne M Smith; Alexander L Greninger; Joseph L Derisi; Don Ganem
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  Borna disease virus (BDV) circulating immunocomplex positivity in addicted patients in the Czech Republic: a prospective cohort analysis.

Authors:  Sylva Rackova; Lubos Janu; Hana Kabickova
Journal:  BMC Psychiatry       Date:  2010-09-08       Impact factor: 3.630

8.  Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.

Authors:  O Planz; L Stitz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 9.  Exploring the cerebellum with a new tool: neonatal Borna disease virus (BDV) infection of the rat's brain.

Authors:  Mikhail V Pletnikov; Steven A Rubin; Timothy H Moran; Kathryn M Carbone
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  Avian bornaviruses in psittacine birds from Europe and Australia with proventricular dilatation disease.

Authors:  Herbert Weissenböck; Tamás Bakonyi; Karin Sekulin; Felix Ehrensperger; Robert J T Doneley; Ralf Dürrwald; Richard Hoop; Károly Erdélyi; János Gál; Jolanta Kolodziejek; Norbert Nowotny
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.